Key result
Acute coronary syndromes are linked to ~2-fold higher procoagulant microparticles vs stable disease.
Why the study?
Elevated levels of procoagulant microparticles in peripheral blood of patients with recent plaque disruption and thrombosis were hypothesized but not established.
Are levels of procoagulant microparticles elevated in the peripheral blood of patients with acute coronary syndromes compared to those with stable angina or noncoronary heart disease?
Observational (n=61)
Are levels of procoagulant microparticles elevated in the peripheral blood of patients with acute coronary syndromes compared to those with stable angina or noncoronary heart disease?
High levels of procoagulant endothelial microparticles are present in the circulating blood of patients with ACS, suggesting a potential role in the generation and perpetuation of intracoronary thrombi.
Answers are grounded in this paper and cite their sources.
May support endothelial microparticle role in ACS thrombosis; hypothesis-generating and should not yet change practice.
BACKGROUND: Apoptotic microparticles are responsible for almost all tissue factor activity of the plaque lipid core. We hypothesized that elevated levels of procoagulant microparticles could also circulate in the peripheral blood of patients with recent clinical signs of plaque disruption and thrombosis. METHODS AND RESULTS: We studied 39 patients with coronary heart disease, including 12 patients with stable angina and 27 patients with acute coronary syndromes (ACS), and 12 patients with noncoronary heart disease. We isolated the circulating microparticles by capture with annexin V and determined their procoagulant potential with a prothrombinase assay. The cell origins of microparticles were determined in an additional 22 patients by antigenic capture with specific antibodies. The level of procoagulant microparticles did not differ between stable angina patients and noncoronary patients (10.1+/-1.6 nmol/L phosphatidylserine [PS] equivalent versus 9.9+/-1.6 nmol/L PS equivalent, respectively). However, procoagulant microparticles were significantly elevated in patients with ACS (22.2+/-2.7 nmol/L PS equivalent) compared with other coronary (P<0.01) or noncoronary (P<0.01) patients. Microparticles of endothelial origin were significantly elevated in patients with ACS (P<0.01), which suggests an important role for endothelial injury in inducing the procoagulant potential. CONCLUSIONS: High levels of procoagulant endothelial microparticles are present in the circulating blood of patients with ACS and may contribute to the generation and perpetuation of intracoronary thrombi.
No takes yet. Share an insight, caveat, or question.
Mallat et al. (2000) conducted an observational in Acute coronary syndromes (n=61). Acute coronary syndromes vs. Stable angina or noncoronary heart disease was evaluated on Level of procoagulant microparticles (nmol/L phosphatidylserine equivalent) (p=<0.01). Acute coronary syndromes were associated with elevated levels of procoagulant microparticles compared with stable angina or noncoronary disease.
Synapse has enriched 10 related papers. Consider them for comparative context: